Molecular pathways: targeting ETS gene fusions in cancer.
about
Discovery and Classification of Fusion Transcripts in Prostate Cancer and Normal Prostate TissueXRP44X, an Inhibitor of Ras/Erk Activation of the Transcription Factor Elk3, Inhibits Tumour Growth and Metastasis in MiceDirect inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids.Discovering and understanding oncogenic gene fusions through data intensive computational approachesThe ETS family of oncogenic transcription factors in solid tumours.Etv2 and fli1b function together as key regulators of vasculogenesis and angiogenesis.Estrogen receptor α enhances the transcriptional activity of ETS-1 and promotes the proliferation, migration and invasion of neuroblastoma cell in a ligand dependent manner.Gene fusions in soft tissue tumors: Recurrent and overlapping pathogenetic themesTranslational and clinical implications of the genetic landscape of prostate cancer.The emerging complexity of gene fusions in cancer.Inhibiting DNA-PKCS radiosensitizes human osteosarcoma cells.The context of prostate cancer genomics in personalized medicine.Metabolic modulation of Ewing sarcoma cells inhibits tumor growth and stem cell properties.Androgen enhances the activity of ETS-1 and promotes the proliferation of HCC cells.Proteomic Characterization of Prostate Cancer to Distinguish Nonmetastasizing and Metastasizing Primary Tumors and Lymph Node Metastases.TMPRSS2-ERG gene fusion is rare compared to PTEN deletions in stage T1a prostate cancer.Precision medicine applications in prostate cancer.Recent advances in prostate cancer research: large-scale genomic analyses reveal novel driver mutations and DNA repair defects
P2860
Q26997884-74CB5D47-D52D-4D05-A967-48C9656F4794Q27333970-F93C80BD-E727-456A-815A-9FB51C4919F2Q30278518-13CB06E1-2FB1-4BF8-A5CA-D5CC49F9CAA7Q31083417-91692D97-AC80-40C0-BC26-75BD7E39AC7AQ34555986-43FDD7B3-992B-45E2-8895-B79FCE57BB4EQ35594958-73EEE9A8-A4A6-4D81-A928-F26FE03DC8EEQ35677586-60AFBD43-DAFB-418A-900D-293A83767AE9Q37234080-EF90AA23-2C8F-48BD-BF70-5387398CD032Q37270512-2DB01081-242D-47F0-B127-CB3652A5473BQ38496502-87412308-63CB-488E-9EE2-1F3B7FE3237BQ38712083-8F56C92E-D039-4BC8-A0F3-E6DD42AB85BEQ41839243-EF66FA50-0CC8-4CE6-9494-B56ADD2C5209Q47101870-75B60D3A-3C4C-4830-858F-0BF885BC044DQ47193705-680301D1-FE2D-44DC-942C-4500C994576CQ47257677-C04E3CFC-350B-41E1-8DED-D2AC5F42A3C8Q51586225-73FE6AA6-BC9C-4846-9DFE-DE1CAB7834D6Q55439000-E94C3C93-02B3-4153-A52B-17593E7EBAA5Q57108205-419F6A0D-80B9-453C-9510-5C60913CA91A
P2860
Molecular pathways: targeting ETS gene fusions in cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Molecular pathways: targeting ETS gene fusions in cancer.
@ast
Molecular pathways: targeting ETS gene fusions in cancer.
@en
Molecular pathways: targeting ETS gene fusions in cancer.
@nl
type
label
Molecular pathways: targeting ETS gene fusions in cancer.
@ast
Molecular pathways: targeting ETS gene fusions in cancer.
@en
Molecular pathways: targeting ETS gene fusions in cancer.
@nl
prefLabel
Molecular pathways: targeting ETS gene fusions in cancer.
@ast
Molecular pathways: targeting ETS gene fusions in cancer.
@en
Molecular pathways: targeting ETS gene fusions in cancer.
@nl
P2093
P2860
P1476
Molecular pathways: targeting ETS gene fusions in cancer.
@en
P2093
Arul M Chinnaiyan
Felix Y Feng
J Chad Brenner
Maha Hussain
P2860
P304
P356
10.1158/1078-0432.CCR-13-0275
P407
P577
2014-06-23T00:00:00Z